According to Entera Bio's latest financial reports the company has $6.91 Million USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $11.01 M | -10.48% |
2022-12-31 | $12.3 M | -50.55% |
2021-12-31 | $24.89 M | 189.68% |
2020-12-31 | $8.59 M | -43.41% |
2019-12-31 | $15.18 M | 31.8% |
2018-12-31 | $11.52 M | -1.92% |
2017-12-31 | $11.74 M | 182.15% |
2016-12-31 | $4.16 M | 245.48% |
2015-12-31 | $1.2 M |